epidemic

May 18, 2020

The neutralizing antibody, called S309, is on an accelerated path toward clinical trials

February 21, 2020

Several new findings on how the virus’ cell entry tools operate could expedite the design of vaccines, antibodies, antivirals and other therapeutics.

Subscribe to epidemic